16 computer-programmer-"Prof"-"Washington-University-in-St" Postdoctoral positions at University of Oxford in United Kingdom
Sort by
Refine Your Search
-
. Keith Channon – a 5 year renewable award that underpins the work of the group. You will lead a programme of research in the molecular mechanisms of cardiovascular disease, that may include a range of
-
and Prof Paul Shearing. The post is funded through a strategic research partnership and is fixed term for up to 2 years. To support the programme, the post holder will be required to carry out research
-
on evaluating the abilities of large language models (LLMs) of replicating results from the arXiv.org repository across computational sciences and engineering. You should have a PhD/DPhil (or be near completion
-
support a high-value materials characterisation programme as a postdoctoral researcher. The ability to think outside the box with creativity, along with having the drive and ambition to develop those ideas
-
The Impact and Shock Mechanics Laboratory (ISML) is seeking a highly motivated scientist to support a high-value materials characterisation programme as a postdoctoral researcher. The ability
-
Programme Manager, using the contact details below. Only online applications received before 12.00 midday on 29th August will be considered. Interviews will be held as soon as possible thereafter
-
development (ECD) and raise global visibility of climate impacts on ECD. The post holder will be a member of Climate Research Programme at ECI in SoGE, reporting to Dr Neven Fučkar, Senior Researcher, and there
-
ability to contribute ideas for new research projects and research income generation. Previous research experience in one or more areas relevant to the research programme. For example: probabilistic machine
-
and leading a programme of numerical simulations relating to all aspects of our research on P-MoPAs; using particle-in-cell computer codes hosted on local and national high-performance computing
-
Medicine, University of Oxford is to re-programme immune cells as part of a larger programme to develop novel therapeutics (viral vector and/or extracellular vesicle-based) for myocardial regeneration. Key